MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.
Uchihara Y, Umeda K, Yamada Y, Ito H, Tasaka K, Isobe K, Akazawa R, Kawabata N, Saida S, Kato I, Hiramatsu H, Noguchi T, Sakamoto A, Arakawa Y, Arakawa A, Yamamoto N, Hosoya Y, Uemura S, Watanabe KI, Sano H, Taga T, Takita J.
Uchihara Y, et al. Among authors: umeda k.
Cancer Sci. 2024 Oct;115(10):3394-3402. doi: 10.1111/cas.16297. Epub 2024 Jul 30.
Cancer Sci. 2024.
PMID: 39080996
Free PMC article.